Defending and Reclaiming WHO’s Capacity to Fulfil its Mandate

This article highlights key touchstones for reflections on WHO’s role in the international health arena and raises a number of possibilities, relating to language, propaganda even, and power, which could contribute to reclaiming WHO’s capacity to unequivocally work for peoples’ health

Defending and Reclaiming WHO’s Capacity to Fulfil its Mandate 

Suggestions from a Perspective of Language and Power

By Judith Richter[i]

Independent Scholar

 

Another ‘reform’ of WHO?

2021 will be a decisive year for the World Health Organization, the highest health authority of this world, whose decisions we must be able to trust as the discussions about its role in the public management of the Covid-19 pandemic has shown.

When President Trump started threatening WHO with the withdrawal of the United States funding, the government of Germany said that, even if the Democratic Party were to win and reinstate US-membership of WHO, there would still be a need to discuss reforming WHO. The problem is that WHO has been reformed under neoliberal ideology for over 20 years and unfortunately, WHO Member-states, as well as senior WHO officials, have not always played a constructive role in the reform of this UN agency. [ii]

In this short text, I raise a number of possibilities, relating to language, propaganda even, and power, which could contribute to reclaiming WHO’s capacity to unequivocally work for peoples’ health.

But before that, let us look at key touchstones for reflections on WHO’s role in the international health arena:

Remember WHO’s constitutional mandate and core-functions

WHO’s objective to work for the “attainment by all peoples of the highest possible level of health” (Article 1) where health is understood as “a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity….” (preamble)

WHO’s constitutional function to “act as the directing and co-ordinating authority on international health work.” (Article 2a)

WHO’s role as regulatory and standard setting body in international health matters. (Articles 2k and 2u)

WHO’s duty to “assist in developing an informed public opinion among all peoples on matters of health.” (Article 2r)

And “generally, to take all the necessary action to attain the objectives of the Organization.” (v)

The people involved in establishing this UN specialized agency after the second World War also stressed:

“Informed opinion and active co-operation on the part of the public are of the utmost importance in the improvement of the health of the people”; and

“Governments have the responsibility for the health of their peoples which can be fulfilled only by the provision of adequate health and social measures.” (Preamble) [iii]

Harmful changes

But governments have often hindered efforts undertaken in the interests of their people due to the rise of neoliberal ideology. Harmful changes resulting from the neoliberal restructuring of WHO and the international health arena include:

1) a gradual narrowing and re-definition of the role of WHO in the international public health arena – more or less reducing WHO’s role to that of a broker of public-private partnerships and part of a global ‘multi-stakeholder governance’ system.

2) the weaving of opaque webs of influence between mega-philanthropies, transnational corporations, WHO (and other UN agencies), government institutions, academics, and a number of public-interest-Non-State actors (PINGOs and civil society organizations and networks) which influence our health policies more than we think.

3) the framing of a neoliberal multi-stakeholder/partnership narrative, including the redefinition of key-political and legal terms, in a way that prevents open and informed discussions and decisions and undermines WHO’s mandate to safeguard international public interests.

4) the rise of a culture of secrecy and censorship which has gradually seeped into all spheres.

Language and power

But we are not powerless in the face of these changes. Insights from language (including propaganda) as power can help us to question these harmful redefinitions and narratives (the storylines which may shape politics and our lives). This is an entirely cost free endeavour which will allow all relevant public actors to truly work towards Health for All.

More clarity in language is an indispensable ingredient in discussions on how to undo harmful neoliberal restructuring of WHO and other UN agencies and problematic public-private webs of influence. I suggest undoing harmful language changes through three strategies:

  • Identifying and rejecting ‘dangerous non-sense’ in neoliberal narratives and terminology
  • “Calling a Spade, a Spade” and replacing problematic terms by less-value laden terms
  • Recovering, and further clarifying, key legal concepts – correct WHO’s misconception and popular misunderstandings of conflict of interest.

I elaborate on these three strategies below: 

  1. Identify and reject dangerous ‘non-sense’ in neoliberal narratives and terminology

Nobody needs to be an academic expert to identify when they see ‘non-sense’. But many may be intimidated by the volumes of official and academic writing which asserts:

In complex situations ‘all stakeholders’ need to work together in ‘partnership’

This, and similar, sentences are presented as an ‘imperative’.

However are simply non-sense, but dangerous non-sense! It is time to reject it!

This alleged ‘imperative’ is part of neoliberal reframing of narratives and key concepts.

Of course, it would be ideal if all societal actors worked harmoniously together when there is an important societal problem. But we all know that this does not correspond to reality, especially when one of these ‘partners’ or ‘stakeholders’ is a powerful for-profit actor who is invited into various fora, on the neoliberal principle of ‘trust’ associated with these arrangements.  French popular wisdom warns “you do not invite the wolf into the sheep pen.” And literature in political science, as well as literature on conflicts of interest in public service, or conflicts of interest in medicine, is full of examples why corporations should not be part of certain decision-making processes. [iv]

Yet the above empty slogan has given rise to plutocratic ‘governance’ (decision-making) systems with totalitarian features. In other words, systems where money, not people (interests), rule (often through manipulation) and where critics are sidelined and silenced.

The draft concept paper underlying WHO’s current Global Work Plan (GWP) is based on such a partnership view. If one undertakes a simple analysis of its discourse by asking “What is said? How is it said? And “What is left out?”, a key suggestion in this document was for WHO to become a humble broker of multi-stakeholder partnerships and part of what was presented as a harmonious, evolving, system of multi-stakeholder governance in health. WHO’s regulatory function of corporate practices – which is distinct from standard setting function – seems to have been lost.[v]

Networks challenging the above imperative and insisting on questioning partnership-approaches, and such as the International Action Network on Infant Feeding (IBFAN), are being discredited and defunded on the grounds that they are not joining the “narrative of the 21st century”.[vi]

Critics have often failed to deconstruct – to fully take apart – such non-sensical terms and narratives. It is not enough, for example, to state that there is a need to consider power differences between business- and civil society- ‘stakeholders’ because this does not challenge the idea that social actors, simply because they have an interest ‘at stake’, are legitimate stakeholders in public affairs; it implicitly reinforces the stakeholder discourse. Calling all kind of societal actors ‘stakeholders’ or ‘partners’ contributes to blurring of fundamental differences between actors in terms of power, interests, and legitimate societal roles and has favoured the rise of public-private hybrids which have acted as Trojan horses for business interests.[vii]

Remember: People are human rights holders whose rights UN agencies are meant to protect, promote, and respect.[viii] Transnational corporations (TNCs) are artificial legal entities whose key driver is profit-making for shareholders. Their power – including that of political lobbying against transnational public-interest regulation – should be kept in check by our governments and the intergovernmental system.

Dangerous ‘non-sense’ is also the more recent redefinition of key concepts such as ‘civil society’ to include transnational corporations (TNCs) and their associations, and of ‘academia’ to include (e.g. corporate-funded) think tanks.

Public-interest actors can of course, where appropriate, interact with business actors. For example, under the late Dr. Halfdan Mahler, WHO cooperated with pharmaceutical companies in its Tropical Disease Research Programme (TDR). At the same time, Dr Mahler did his best to work for transnational regulation of harmful business practices and of the products of pharmaceutical, food, tobacco, and alcohol companies, and towards systems that provide access to Health for All, including access to affordable essential medicines.[ix]

Times have changed. Today there is a need to:

  • re-establish a clear separation of spheres, and an ‘arms-lengths’ distance between public-interest actors and big business actors as well as hyper rich funders and their mega-foundations
  • protect sensitive public interest inside information from firms and associated actors instead of inviting them into fora where they do not belong and giving them roles that are inappropriate
  • allow for public scrutiny
  • and protect whistleblowers – persons who report wrongdoing in the international public interest – and listen carefully to them, instead of sidelining, silencing, or persecuting them.[x]
  1. “Call a spade a spade” – Be specific and replace problematic terms by less-value laden terms

The following terms should never be used without reflection. They should be replaced by terms which do not promote undue influences by giant firms and wealthy funders. These terms include:

  • Partners, partnership, in particular public-private partnership (PPP);[xi]
  • Stakeholder, multi-stakeholder-anything: such as MS-partnership (MSPs), MS-dialogue, MS-platform, MS-governance;
  • Governance.

In fact, PPPs and MS-anythings usually denote public-private hybrids and hybridization (PPHs) – the blurring of boundaries between private/business sphere and the public sphere. They introduce, and legitimize, undue influence of big corporations and mega-funders. Since the introduction of the term governance in the international arena, and the link with a redefined “stakeholder” term, the term multi-stakeholder governance simply means inviting corporations and big funders into decision-making.

This is why health activists working for Health for All, which includes appropriate health care systems accessible to all, and regulation of harmful practices of transnational corporations, have called neoliberal PPPs and MS-arrangements Trojan horses.

Scholars such as Susan George, who has long worked against the seizing of power by corporations, advocates abandoning the terms stakeholder and governance in public discourse. She stresses: “Non-native English speakers… don’t necessarily realize that in English a stake is always concerned with money, property or a bet of some kind. In the days of the American frontier, a pioneer moving West could lay, or ‘stake’ a claim to land, marking it physically with posts – or stakes at the corners…” [xii]

Two further  reflections may help to undo the power of the multi-stakeholder governance notion:

I would like to remind people that the term stakeholder has been redefined in a Novartis-sponsored publication from then UN Secretary General Kofi Annan’s definition of stakeholders as: “those individuals and groups that have an interest, or take an interest, in the behaviour of a company… and who therefore establish what the social responsibility of a company entails” to a definition of stakeholders as “those who have an interest in a particular decision, either as individuals or as representatives of a group. This includes people who influence a decision, or can influence it, as well as those affected by it.”[xiii]

It is also useful to remember that the term governance comes from the Greek gybernan, which originally means to be at the rudder, to steer a boat. What must be vigorously defended is for our ‘health boat’ to be steered in the public interest, with the aim of achieving Health for All. (according to a map and by actors, which allow to reach Health for All.)

  1. Recover and further clarify key legal concepts – conflict of interest (a conflict within an actor)

The neoliberal restructuring can also be reversed by recovering legal meanings of redefined key-concepts.

For example, the power of the broad stakeholder definition can be undone by pointing out that the law continues to define a stakeholder as “any person/group which can affect/be affected by the actions of a business. It includes employees, customers, suppliers, creditors and even the wider community and competitors.”[xiv]

But most important is to recover the meaning of conflicts of interest. During the last ‘reform’ of WHO under Dr. Margaret Chan, Member States had asked WHO’s Secretariat to clarify the concept of conflict of interest and help distinguish appropriate from inappropriate interactions with corporations and other Non-state actors.

Instead, WHO actively redefined the conflict of interest (COI) concept in a way that makes genuine conflict of interest regulation impossible. In its work, the Secretariat build on, rather than publicly rejected, a misleading COI definition that had been developed in a Gates-funded project for use in the Scaling-Up Nutrition (SUN) initiative, a public-private hybrid of which WHO and UNICEF are part.[xv]

The erroneous conception of conflict of interest, which is used in FENSA, WHO’s Framework of Engagement with Non-state Actors, unduly influences WHO’s relations with TNCs and wealthy funders. Among other things, it does not posit conflicts of interests as conflicts WITHIN an actor, but conflicts BETWEEN actors.[xvi] World expert on conflicts of interest in medicine, Professor Marc Rodwin, warned the agency since its Technical consultation “Addressing and managing conflicts of interest in the planning and delivery of nutrition programmes at country level” in 2015, that wrong conceptions may actually lead to an increase of conflicts of interest, among others by diverting attention from identification and genuine regulation of conflicts of interest to risk assessments. He proposes as most suitable COI definition for WHO engagement with Non-state Actors a conception which takes financial conflicts of interest and loyalty conflicts into account.[xvii] In such a conception it becomes clear that public-private arrangements in which public-interest actors are asked to look for win-win situations for both parties are placing them into a loyalty conflict. Is this why SUN’s Gates-funded project had to redefine conflicts of interest?

Non law-based COI concepts, such as the notion of ‘intellectual conflicts of interest’, risk sidelining critical civil society actors or scientists from public debates. This situation is compounded by a problematic confidentiality clause for WHO experts.

In the medical sphere, it is long known that individual researchers, health professionals, or civil servants, cannot resolve certain conflicts of interest, if their institution is caught in what is called an institutional conflict of interest. If WHO had referred to existing institutional conflict of interest definitions, its leaders could have pointed out to its Member States that they have placed our specialized health agency into a severe institutional conflict of interest – a conflict between its mandate (its ‘primary interest’) and the need to collect funds – by their long-standing refusal to fully fund WHO via assessed contributions (which are the equivalent of taxes).

Some political and legal scientist have gone beyond the institutional conflict of interest frame by developing an institutional corruption/integrity theory. It clearly identifies the risk that public-interest organizations’ mandates can be undermined – and their agendas shifted – depending on where their money comes from.

Legal expert and ethicist Jonathan Marks writes in his book The Perils of Partnership that public agencies need not only conflict of interest policies but also “comprehensive counterstrategies to insulate themselves from corporate influence”. And he asserts, “public health needs another paradigm”.[xviii]

Both, institutional conflict of interest, and institutional corruption/integrity, frameworks center on the need to ensure the integrity, independence, and trustworthiness (respectively credibility) of public institutions. This is a complex task. It entails ensuring that they have the capacity and political will to fulfill their public mandates.

WHO’s Framework of Engagement with Non-state actors (FENSA) lists the above three terms under its ‘principles’ of engagement. This triad is further key-touchstone when trying to recover WHO’s capacity to work for peoples’ right to health.

Many of the neoliberal ‘principles’ of engagement need to be questioned. It should be noted that the term ‘trust’ does not figure under FENSA’s principles of engagement. Member States have eliminated during the discussions on earlier drafts. It should therefore also be eliminated from principles of all other ‘engagement’ policies in public health which involve cooperation with private-sector actors.

However, it is important to recognize the limits of WHO’s Secretariat. They are set by funding and Member State willingness to act in the international public interest rather than in their narrow national interests or that of their transnational companies. The United States and EU Member States, for example, have often resisted effective regulation of harmful TNC practices and reshaping of pharmaceutical and health systems policies in the public interest. As we can see right now, China can prevent WHO, and journalists, from undertaking genuine investigations into the origins of the Covid-19 virus[xix]

Full public funding and the recovery of WHO’s mandate

To resolve WHO’s key institutional conflict of interest, to enable it to recover its integrity, independence and trustworthiness, any Member State or civil society actor criticizing WHO’s handling of the world’s health problems, must therefore also call to undo the long-standing ban on raising assessed Member state contributions to WHO, as critics supportive of WHO have said for two decades.

Today, the question is: Will WHO’s Director-General and its high-level officials engage in, and support, efforts to defend the mandate and core-functions of WHO and start extricating our UN specialized agency for health from opaque and inappropriate relations with venture philanthropies and transnational corporations? Otherwise, our tax money contributes to further strengthening public-private, plutocratic, global governance systems in health.

 

Endnotes

[i] Independent scholar. Author of the books Holding Corporations Accountable and Public-private partnerships and international health policy making: How can public interests be safeguarded? and numerous publications ranging from analysis of corporate lobby against international regulation to work on conflicts of interest regulation and other ways to maintain the integrity of public-health policy making. Declaration of interests: throughout my long career as sociologist, I have never relied on corporate or venture philanthropy funding. This paper was self-funded. Acknowledgments: I thank Alison Katz for language editing and editorial advices.

[ii] Birn, Anne-Emanuelle and Nervi, Laura. “(Re-)Making a People’s WHO,” American Journal of Public Health, 110: 9 (September 2020): e1-e2. https://doi.org/10.2105/AJPH.2020.305806 (see author’s website for French, Spanish and German versions)

Richter, J. (2012) “WHO reform and public interest safeguards: An historical perspective. Editorial.” Social Medicine 6 (3): 141-150, April 2012 (& Spanish translation) www.medicinasocial.info/index.php/socialmedicine/article/viewArticle/637

[iii] https://www.who.int/about/who-we-are/constitution; https://apps.who.int/gb/bd/PDF/bd47/EN/constitution-en.pdf?ua=1 , accessed 12.01.2021

[iv] Since Corona-policies have started impacting peoples’ lives it starts becoming common knowledge that companies which are producing emergency vaccines are not just charitable institutions but have clear financial interests at stake;  unfortunately there is too little research and media coverage examining how concretely the Bill and Melinda Gates foundation and its’ webs of influence have been shaping – and continue shaping – WHO’s and national advices on how to address this latest transmissible health challenge. Is it due to their influence that the current narrative presents widespread vaccination as the light at the end of the tunnel? To what degree was the neglect of low-tech approaches, such as the provision of FFP2/N95 respirators and plexi-shields in shops and offices due to plans elaborated in Gates-corporate-webs of influence?

Most media coverage focusses on debunking wild theories on the role of Bill Gates which circulate in social media, some newspapers present him as a hero in the ‘war on the virus’. Thorough analyses of Gates’s role in shifting and influencing international and national health agenda risk to be sidelined even further sidelined as yet another ‘conspiracy theory.’

[v] Richter, J. (2017) Comments on Draft Concept Note towards WHO’s 13th General Programme of Work, 14 November, http://g2h2.org/wp-content/uploads/2017/09/Judith-Richter-1.pdf

Richter, J in cooperation with Alessia Bigi (2017) “Comment on WHO’s draft 13th General Programme of Work”, IBFAN-GIFA Briefing Paper, 28 November https://www.gifa.org/wp-content/uploads/2017/11/IBFAN_GIFA_2017_comment-on-dGPW13.pdf 

[vi] Richter, J (2015) “Conflicts of interest and global health and nutrition governance – The illusion of robust principles,” BMJ RR, 12 Feb., www.bmj.com/content/349/bmj.g5457/rr

[vii] The term stakeholder is not easy to translate into other languages. A German translation as ‘Interessensträger’ (interest-bearer), for example, is problematic. It fails to address the problem of redefinition of the term stakeholder; and this translation does not contribute to undoing the discursive and propagandist power of the term stakeholder in anglo-saxon literature and official documents.

[viii] This was stressed by Nora McKeon in her neglected comment on the FAO HLPE Report on Multi-stakeholder partnerships to finance and improve food security and nutrition in the framework of the 2030 Agenda http://www.fao.org/publications/card/en/c/CA0156EN/

[ix] Richter, J. (2001) Holding corporations accountable: corporate conduct, international codes, and citizen action. London & New York: Zed Books

[x] https://whistleblowerprotection.eu/who-is-a-whistleblower/

[xi] For a shift in the meaning of partnership, see e.g. Richter, J (2005) Global partnerships and Health for All: Towards an institutional strategy. A discussion paper prepared for WHO’s Department of Government, Civil Society and Private Sector Relations (GPR). Geneva, WHO, 20 pages, 2005 http://info.babymilkaction.org/files/Richter%20Global%20Partnerships%20and%20health%20for%20all.pdf

[xii] Susan George (2015) Shadow Sovereigns: How global corporations are seizing power, Polity Press, Cambridge, p. 7-8

[xiii] Hemmati, M. (2002). Multi-stakeholder processes for governance and sustainability: beyond deadlock and conflict. London, Earthscan. Forother references &context of this shift, see Richter, J. (2002). Dialogue or engineering of consent? Opportunities and risks of talking to industry. Geneva, International Baby Food Action Network/Geneva Infant Feeding Association (IBFAN-GIFA), p. 18 ff.

[xiv] It comes from the “Stakeholder theory” which “states that a company owes a responsibility to a wider group of stakeholders, other than just shareholders.” See Corplaw Admin. (2013, July 16). Shareholder and stakeholder theories of corporate governance. Retrieved from Corpolaw: https://blog.corplaw.ie/bid/317212/Shareholder-Stakeholder-Theories-Of-Corporate-Governance

[xv] Richter, J (2017) “Comments on Draft Approach for the prevention and management of conflicts of interest in the policy development and implementation of nutrition programmes at country level”, WHO online consultation, 29 October 2017, http://www.who.int/nutrition/consultation-doi/judith_richter.pdf

[xvi] Richter, J. “Time to debate WHO’s understanding of conflicts of interest.” British Medical, Journal (BMJ) rapid response, 22 October 2015, www.bmj.com/content/348/bmj.g3351/rr.

Many civil society organisations still do not seem to have understood that they replicate this conception in some way.  They still talk about conflicting – and diverging – interests BETWEEN public and for-profit interest actors as conflicts of interest. For a reference concerning Gates and Member State funding and WHO’s institutional conflict of interest, see the section on CoI in :

Birn, A.-E. & J. Richter (2019) U.S. Philanthrocapitalism and the Global Health Agenda: The Rockefeller and Gates Foundations, Past and Present. Health Care under the Knife:  Moving Beyond Capitalism for Our Health. eds. Howard Waitzkin and the Working Group for Health Beyond Capitalism, Monthly Review Press (advance chapter see) http://www.peah.it/2017/05/4019/

[xvii] Marc A. Rodwin (2020) .WHO’s Attempt to Navigate Commercial Influence and Conflicts of Interest in Nutrition Programs While Engaging With Non-State Actors: Reflections on WHO Guidance for Nation States; Comment on “Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool”, IJPM, September https://www.ijhpm.com/article_3914.html

[xviii] Marks, Jonathan H. (2019) The perils of partnership: industry influence, institutional integrity, and public health, Oxford University Press, New York

[xix] A recent article argues that it may have created during research on vaccines to immunize against harmful corona-viruses – and this “lab-escape theory” does not sound implausible https://nymag.com/intelligencer/article/coronavirus-lab-escape-theory.html

News Flash 414: Weekly Snapshot of Public Health Challenges

News Flash Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

News Flash 414

 Weekly Snapshot of Public Health Challenges

 

2020: a Year in Review through PEAH Contributors’ Takes by Daniele Dionisio

The (Re)Construction of the World: Aid. Solidarity. Politics. Online conference February 12-14, 2021, with Achille Mbembe, Susan Buck-Morss, Rita Segato, Ulrike Herrmann, Sandro Mezzadra, among others 

EU Development Policy in 2021: Greater than the Sum of Its Parts? 

WHO informal consultation (3 December 2020) addressed concerns on price transparency and shortages 

Italy and the Dubious Honor of Chairing the G20 

Africa’s Road to Recovery in 2021 is a Fresh Start

Coronavirus disease (COVID-19) Weekly Update 

Africa: Covid-19 Death Toll Exceeds 74,000 Across Continent 

Rapid Increase In COVID Cases ‘Not Due To The Variant’, WHO Says 

WHO calls for new names for Covid variants to avoid country stigma 

WHO Stresses That China Trip To Investigate SARS-CoV2 Virus Origins is Not About Blame; Urges All Countries to Improve Genome Sequencing Research 

WHO Has ‘Outsourced’ Its Role On Vaccine Access – Civil Society Groups Claim 

Webinar registration: Learning Session: European Citizens’ Initiative & Access to Covid-19 Vaccines Jan 19, 2021 02:00 PM in Brussels 

Ensuring equitable access to vaccines for refugees and migrants during the COVID-19 pandemic 

UK meets £250m match aid target into COVAX, the global vaccines facility 

Poorer countries could start getting COVID vaccines this month-WHO 

Opinion: US development organizations must collaborate on COVID-19 vaccine distribution strategy 

EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca 

Research shows Pfizer vaccine works against mutations | New Mutant Strain | Britain | South Africa 

Arthritis drugs could help save lives of Covid patients, research finds 

How can we overcome pandemic fatigue in 2021? 

Global Funding Across U.S. COVID-19 Supplemental Funding Bills 

UNICEF, WHO, IFRC and MSF announce the establishment of a global Ebola vaccine stockpile 

Implementation of tuberculosis preventive treatment among people living with HIV, South Sudan 

Death on the Central Mediterranean: 2013-2020 

Contributions From APAN During Disasters by Tanushree Mondal

Can the World Tackle the Food Insecurity Crisis in 2021? 

One Planet Summit: no climate fix without biodiversity 

The 2020 China report of the Lancet Countdown on health and climate change 

Countries face emissions ‘cocktail’ from waste burning 

Renewable Energy Transition Key to Addressing Climate Change Challenge

 

 

 

 

 

 

 

The ISOHA Europe Virtual Conference 2021

A snapshot here on the Europe Virtual Conference 2021 currently being held by the International Student One Health Alliance (ISOHA) as a week-long webinar series from 11-17 January 2021

 

The ISOHA Europe Virtual Conference 2021

 

The ISOHA Europe Virtual Conference 2021 currently being held in Romania, Europe, is a week-long webinar series from 11-17 January 2021, featuring speakers from different fields of One Health each evening. The event is attended by 600 registered participants and over 100 attendees live on Zoom each evening.

More information and registration here

 https://www.youtube.com/watch?v=b735oWTRB9E

 

Further to the ISOHA announcement, find intro slides below  for the January 16 webinar session held by George Lueddeke Chair, International One Health for One Planet Education Initiative (1 HOPE) – based generally on his recently PEAH published commentary Rebuilding Trust  and Compassion in a Covid-19 World.

 

News Flash 413: Weekly Snapshot of Public Health Challenges

News Flash Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

News Flash 413

Weekly Snapshot of Public Health Challenges

 

Aid policy trends to watch in 2021 

WEMOS: TOWARDS HEALTH FOR ALL IN THE YEAR OF CORONA: OUR HIGHLIGHTS OF 2020 

Mexico shares Biden focus on migration’s root causes, ministry says 

What Democratic control of the Senate could mean for US foreign aid  

Webinar registration: Series of public briefings and debates ahead of WHO EB 148 

WHO’s Attempt to Navigate Commercial Influence and Conflicts of Interest in Nutrition Programs While Engaging With Non-State Actors: Reflections on WHO Guidance for Nation States Comment on “Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool” 

WHO Secretariat: report and proposal on EB agenda item 19.2, Involvement of non-State actors in WHO’s governing bodies 

148th Session of the WHO Executive Board: Another waste of time – or time to restore WHO as directing global health authority? Series of public briefings and debates hosted by G2H2, 11-15 January 2021 

Coronavirus disease (COVID-19) Weekly Update 

G7: Make Plans to Share Excess Vaccine Now 

WHO Calls On Europe To Curb Spread of UK Virus Variant – Researchers Warn South African Mutations May Be More Vaccine Resistant 

South Africa to Start Vaccinating Health Workers As WHO Warns Against Bilateral Deals Outside COVAX 

European Commission authorises second safe and effective vaccine against COVID-19 

Public stakeholder meeting on the approval and roll-out of COVID-19 vaccines in the EU Date: 08/01/2021 Location: Virtual meeting, 13:00-15:15 CET 

Webinar registration: Learning Session: European Citizens’ Initiative & Access to Covid-19 Vaccines Jan 19, 2021 02:00 PM in Brussels 

Eyebrows raised over India’s COVID-19 vaccine approval 

ANTICOV Treatment Clinical Trial Crucial for Africa 

Covid: WHO team investigating virus origins denied entry to China  

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults 

COVID-19 Outcomes for Patients on Immunosuppressive Drugs on Par with Non- Immunosuppressed Patients 

Decolonising global health in the time of COVID-19 Mariam O. Fofana in: Global Public Health, 28 Dec  2020 

Human Rights Reader 559 

Study: Warming already baked in will blow past climate goals  

Degradation of Brazil’s Atlantic Forest laid bare 

 

 

 

 

 

 

2020: a Year in Review through PEAH Contributors’ Takes

Authoritative insights by 2020 PEAH contributors added steam to debate on how to settle the conflicting issues that still impair equitable access to health by discriminated population settings worldwide

by  Daniele Dionisio*

PEAH – Policies for Equitable Access to Health

2020: a Year in Review through PEAH Contributors’ Takes

 

Now that ill-fated 2020 just went by – and all of us hope we can finally put its COVID nightmare on the back burner – let me express deep gratitude to the top thinkers, stakeholders and academics who generously contributed articles over the year. Their enthusiasm and commitment meant a lot to PEAH scope and aims, while adding steam to debate on how to settle the conflicting issues that still impair equitable access to health by discriminated population settings worldwide.

Find out below the relevant links:

Fair Research Contracting – Key to Promoting Solidarity for Science and Development in a post-COVID-19 World by Carel IJsselmuiden, Kirsty Kaiser, Abigail Wilkinson, Farirai Mutenherwa 

Covid-19 VIRAT and VRAF Country Assessment Tool: The Need of the Hour by Tanushree Mondal 

Rebuilding Trust and Compassion in a Covid-19 World by George Lueddeke

The Case for Relational Quality Improvement in Health by Maria Kordowicz

Access to Opioid Analgesics for Medical Purposes: a Global Unbalance by Raffaella Ravinetto 

Economic Growth, Accessibility, and COVID-19: a Policy Analysis Examining a Decade of Greater Alcohol Liberalization in Ontario by Yipeng Ge, Elspeth McTavish, Rohit Vijh, Lawrence Loh 

Whistling Past the Graveyard of Dreams: Hard Truths About the Likely Post-Pandemic World by Ted Schrecker 

The State of Oregon’s COVID-19 Response by Susan M. Severance 

Rapid Assessment on the Impact of COVID-19 among Female Sex Workers, Adolescent Girls and Young Women, and Women Living with HIV & AIDS in Uganda by AWAC-Alliance of Women Advocating for Change 

The Effects of the COVID-19 Pandemic on the Health Service Delivery Systems in Uganda by Zziwa Joshua and Bukenya Denis Joseph 

Politics and the Myths Around COVID-19 Pandemic Affecting the Right to Health by Bukenya Denis Joseph and Zziwa Joshua 

Africa’s Innovative COVID-19 Response: The Africa Medical Supplies Platform by Chiamaka P. Ojiako 

Barriers For Migrants by Chamid Sulchan

Migrants in Need: COVID-19 and the Impact on Labor Migrants’ Health, Income, Food and Travel by Olga Shelevakho and Helena Arntz

Toto Care Box: Enhancing Maternal and Newborn Health in Kenya by Reagun Andera Odhiambo

Contribution of the COVID-19 Crisis to Teenage Pregnancy Upsurge: a Case of Mukuru Kayaba Slums, Nairobi Kenya by Reagun Andera Odhiambo 

Substantial Aspects of Health Equity During and After COVID-19 Pandemic: A Critical Review by Erfan Shamsoddin 

The Future Path of U.S. Clinical Research: Bridging Geographic Diversity by Nicole Jarosinski

How to Survive COVID-19: Now and the Future by Subhash Hira, Sudhanshu Malhotra, Santosh Gupta, Kaamila Patherya 

An Economic Prescription for U.S. Healthcare: On Combining Capitalism, Socialism and Sports Competition by Larry J. Pipes 

On Reforming U.S. Healthcare by Larry J. Pipes 

Health Care Reform in The United States: a Call to Action by Susan M. Severance

Labour Migrants in Russia and their Needs by Chamid Sulchan 

How Prepared is Africa for the COVID-19 Pandemic Response? The Case of Ethiopia by Garumma Tolu Feyissa, Lemi Belay Tolu, Alex Ezeh 

Financing Biologic Product in Canada by Malek Ayoub 

Diseases Are Neglected by the Pharmaceutical Industry by Luciana M.N. Lopes and Alan Rossi Silva 

Reflections on the COVID-19 Crisis: Smart Lockdown by Muhammad Usman Khan 

Back to Basics – Lessons Learnt from COVID-19 Pandemic by Meenakumari Natarajan 

Postscript – The World at Risk: Covid-19, Global Sustainability and 1 HOPE by George Lueddeke 

No Exit? The United Kingdom’s Probable Russian Future by Ted Schrecker 

COVID-19 Impact on the Pharmaceutical Industry: Major Challenges and the Way Forward by Aboli Mandurnekar 

Implications of Covid-19 Pandemic on Health Systems by Francisco Becerra-Posada 

Interventions to Curb Covid-19 Spread in a Low-Income Country: Feasibility Challenges by Gertrude Masembe 

Plague and Depression in the Just-In-Time World by Ted Schrecker 

Pharmaceutical Business in Somalia by Mohamed Said Alì 

The World at Risk: Covid-19, Global Sustainability and 1 HOPE by George Lueddeke 

Il Rischio ed i Danni dell’Amianto nella Società, nei Media e nella Letteratura di Francesco Carnevale 

Increasing Uptake of Vasectomy as a Family Planning Method in Uganda by Amon Mulyowa 

Ten Propositions for Global Sustainability by George Lueddeke 

WHAT SHOULD BE A PRIMARY CARE? by Olga Shelevakho

Public Health or Poverty Alleviation? What are Mosquito Nets for? by Gertrude Masembe 

Assessment of Private Wing in Public Hospitals: The Case of St. Paul Hospital Millennium Medical College, Addis Ababa, Ethiopia by Fitsum Girma Habte, Yemisirach Abeje, Girmaye Tamrat Bogale 

Coronavirus – Early Responses by Rosemary Barber-Madden 

Development Cooperation: Concerns and Emerging Challenges by Michael Ssemakula 

HIV Is Not a Verdict: I Love Every Minute of My Life by Olga Shelevakho 

The University in the early Decades of the Third Millennium: Saving the World from itself? by George Lueddeke 

Mitigating and Adapting to the Effects of Climate Change on Health in the Suburbs Through Adaptations in the Built Environment by Debbie Brace, Vanessa Kishimoto, Michelle A. Quaye, Mike Benusic, Louise Aubin, Lawrence C. Loh 

Making Nutrition and Health More Equitable within Inequitable Societies by Claudio Schuftan 

The contributions highlighted above add to PEAH internal posts published throughout the year. Find the links below:

LA SANITA’ AI TEMPI DEL CORONAVIRUS di Marco Geddes da Filicaia review by Daniele Dionisio

Italy Experience with COVID-19 by Daniele Dionisio

Interview to Ms. Gloria Nirere, Menstrual Health Management Trainer in Uganda by Daniele Dionisio

Moreover, as part of PEAH scope and aims, the column titled Focus on: Uganda’s Health Issues continued to serve as an observatory of challenging health issues in Uganda from a comprehensive view encompassing the policies, strategies and practices of all involved actors. 

In the meantime, our weekly page PEAH News Flash has been serving as a one year-long point of reference for PEAH contents, while turning the spotlight on the latest challenges by trade and governments rules to the equitable access to health in resource-limited settings.

Eventually, a new  PEAH: In the Public Eye column was set up during the year  as a gathering place for PEAH quotations from everywhere.

——————————————————

*Daniele Dionisio is a member of the European Parliament Working Group on Innovation, Access to Medicines and Poverty-Related Diseases. Former director of the Infectious Disease Division at the Pistoia City Hospital (Italy), Dionisio is Head of the research project  PEAH – Policies for Equitable Access to Health. He may be reached at: 

d.dionisio@tiscali.it  https://twitter.com/DanieleDionisio https://www.linkedin.com/in/daniele-dionisio-67032053  https://www.facebook.com/PEAH51/?modal=admin_todo_tour

 

PEAH collaborates with a number of non-profit entities. These include, among others:

#MedsWeCanTrust 

G2H2Geneva Global Health Hub 

CEHURD – Center for Human Rights and Development 

Center for the History of Global Development 

Viva Salud 

Asia Catalyst 

MEZIS 

ATTAC 

The 53rd Week Ltd 

Wemos 

Social Medicine Portal 

Health as if Everibody Counted 

COHRED’s Research Fairness Initiative (RFI) 

AFEW International 

TranspariMED 

Medicines and Ethics, Institute of Tropical Medicine, Antwerp

Alliance of Women Advocating for Change (AWAC) 

 

Contributions From APAN During Disasters

The most important aspect that gets affected during disasters is human connectivity. In this regard, APAN (Asia Pacific Advanced Network) has been very much instrumental in making the lives of the research community better and making it more comfortable

By Dr. Tanushree Mondal

Assistant Director of Medical Education, Government of West Bengal

Contributions From APAN During Disasters

 

First published 21 December 2020  https://www.chdgroup.org/policies/contributions-from-apan-during-disasters/


"The General Manager of APAN, Dr Markus Buchhorn is very hopeful that with the passage of the time, APAN can contribute more and more in this uncharted domain and can make an important difference to the broader community and benefit society through that"

 

APAN (Asia Pacific Advanced Network) is a network that connects research and education networks of various economies to one another and this makes it possible to build appropriate networks.

Among the activities of APAN, some are to provide forums for network engineers to build new applications, operate a fellowship program in support of it, adoption of advanced network technologies and regular updating of links, thereby improving the global cooperation from countries like Europe, North and South America, Africa and Arabian countries as well.

In pretty much every country there are research networks that connect all the Teaching institutions, the college, the hospitals, the museums, the cultural institutions on a common platform, the National Research Education Networks (NREN), either deployed by the Ministries of the respective Governing body or through the Universities. What APAN does is partnering of all the NREN in 3 out of the top 5 leading economies of the world, spanning more than half of the world’s population, including many contributors and link owners in a loose and volunteer-based manner. It stretches from Pakistan in the west to Japan in the east and down to Australia, New Zealand in the south. So, it spans the least developing to the most developed countries, creating multiple freeways.  It hopes to extend its domain more in the pacific Islands one day. These networks are the need of the hour while harnessing resilience against disasters. These networks help in moving large data sets and stand unique in their approach for their Out -of-the -Box Thinking and promulgation of Best Practices wherever and whenever they can.

In the remote past, the Disaster Mitigation Working group of APAN collaborated with the UNESCO under the project Connect Asia and promoted gentle partnerships with economies all around and engaged in case studies, numerical simulations, simulation practices and collaboration models and tools. Their domain was far fletched ranging from floods to droughts, Earthquakes, Tsunami, Fires, Smoke, Typhoons, Dust etc. So, in the face of such a Disaster, APAN stands by establishing multiple paths as a way of robust reconstructive and mitigation activity. APAN has the capability of providing such pathways specially during disasters ex. downloading or else uploading terra byte of data on Climate data in Modelling typhoon in the event of a disaster rapidly, running models with artificial intelligence which is in fact a transformative step in restoring and saving lives in a matter of few minutes. It also means accessing Disaster Response Networks by deploying such networks in places which faced a disaster. For ex. An Ad hoc network or a mesh network in the Philippines to support the responders in the region that replaced the local mobile network. In such a way, these networks deliver information, computing capacity whenever required. Such has also been shown in the clinical context of Covid-19 in 2020 through sharing of data. These information help bring in the necessary resources to the places that require the most, thus building resilience of research and science and technology in the support community. So, when such events occur in the future, these resilient networks come to play forefront with their armamentarium.

APAN conducts two meetings in a year crossing the Asia Pacific regions, the last was the APAN 50 at Hongkong in the year 2020, and the next upcoming is the APAN 51 at Islamabad, where there is a whole lot of knowledge sharing and learning between the researchers, the end-user community, the educators, and with the involvement of all its working group ranging from Agriculture, Earth system and sensing, Astronomy, culture, Disaster Management, Medical wing etc.

Much remains undiscovered when it comes to the contribution that APAN has left on the lives of the educators all around the globe, especially during the time of natural disasters or man-made calamities. Though the objectives of APAN have always been to uplift the education and research globally taking it to the next dimension, but it has unknowingly contributed to the medical world time and again, such as during the SARS outbreak, Bird Flu and most recently during the covid-19 pandemic by building human knowledge networks. During the SARS outbreak, when hospitals were all locked down, NREN community built a video-conferencing and IPV6 infrastructure, for the patients, doctors, visitors, administrators to communicate within and outside their community, helping diagnose and provide utmost care and support to its beneficiaries. So, this is one such model that could be replicated in the recent times, as and when required. APAN over time through its collaborative approaches will scale up better for the welfare of communities.

 

 

 

 

News Flash 412: Weekly Snapshot of Public Health Challenges

News Flash Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

News Flash 412

 Weekly Snapshot of Public Health Challenges

 

148th Session of the WHO Executive Board: Another waste of time – or time to restore WHO as directing global health authority? Series of public briefings and debates hosted by the Geneva Global Health Hub
11-15 January 2021, 16.30-18.00 CET 

Health in Development Cooperation and Humanitarian Action report 2020 

2021: research and medical trends in a post-pandemic world 

Coronavirus disease (COVID-19) Weekly Update 

Latest Covid-19 Statistics from African Countries 

WHO-led team expected in China in January to probe COVID-19 origins – experts 

Coronavirus: Commission puts forward rules on rapid antigen tests and secures 20 million tests for Member States  

EMA recommends first COVID-19 vaccine for authorisation in the EU 

EMA organises a second public meeting about the new COVID-19 vaccines 

Coronavirus: Commission concludes exploratory talks with Novavax to secure a new potential vaccine 

Two Billion Doses Secured For COVAX Vaccine Facility – Distribution Will Begin in First Quarter 2021 To High Risk Groups in Low- And Middle-Income Countries 

Decision on intellectual property waiver over Covid technology on hold till 2021; what are the next steps? 

Audio Interview: Covid-19 Vaccine Fundamentals  

‘Urgent info campaigns needed’ on COVID-19 vaccines 

Johns Hopkins Launches New Courses on COVID-19 for Assisted Living and Senior Housing Communities to Address COVID-19 Challenges 

Recommendations for the Overdose Epidemic in the COVID-19 Pandemic 

Africa steps up fight against HIV with trial of new combination vaccines  

Towards a coordinated strategy for intercepting human disease emergence in Africa 

Snakebites Are a Deadly Threat Worldwide. Who’s Behind the Push for a New Treatment?

Human Rights Reader 558 

Migrants Struggle To Access Healthcare, First WHO Study Of Migrant Health During Pandemic Finds 

More funds are required to promote migrants’ health  

The EU Migration Pact: Building a True Partnership with Africa 

After COVID, Locusts And Climate Change Setback Food Security – A ‘Year Of Action’ For 2021 To Advance Global Nutrition Goals 

Children’s Participation in Action and Learning for Nutrition (PCAAN) in Mozambique 

A Pakistani Farmer is Using Technology to Stop Agricultural Exploitation 

EU-Africa partnership needed for transformation of food systems, says experts 

Climate change is destroying people’s lives. Should they be compensated? 

Soil health key to achieving SDGs 

Five Years since the Paris Agreement: The Race to Net Zero Is On 

 

 

News Flash 411: Weekly Snapshot of Public Health Challenges

News Flash Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

News Flash 411 

Weekly Snapshot of Public Health Challenges

 

 

Governments must act fast on consensus supporting historic move to suspend monopolies during pandemic 

Intellectual Property Monopolies Block Vaccine Access  

Nearly 6 Million People Could Be Immunized By Vaccines in 2021 – But Low-Income Countries Risk Being Left Out, Warns BMJ 

Missed opportunity for immunization due to COVID-19  

COVID-19 Vaccine: Reaching People in Areas Controlled by Armed Groups 

What is the ‘know-how gap’ problem and how might it impact scaling up production of Covid-19 related diagnostics, therapies and vaccines? 

World Health Organization’s Censorship Of Report On Italy’s Pandemic Response Sets Dangerous International Precedent – Critics Say  

WHO EXECUTIVE BOARD EB148/1 (annotated) 148th session 14 December 2020 Geneva, 18–26 January 2021 Provisional agenda (annotated)  

Coronavirus disease (COVID-19) Epidemiological Update 

Coronavirus Variant Identified In England 

Fair Research Contracting – Key to Promoting Solidarity for Science and Development in a post-COVID-19 World by Carel IJsselmuiden, Kirsty Kaiser, Abigail Wilkinson, Farirai Mutenherwa 

The role of implementation research for pandemic response 

Covid-19 VIRAT and VRAF Country Assessment Tool: The Need of the Hour by Tanushree Mondal

EU finalizes €500M boost for COVAX 

Canada pledges C$485 million in COVID-19 aid for other nations 

Too Big To Ignore: 7 Recommendations To Address Our Growing Mental Health Crisis 

Study finds malaria drug can also prevent relapse in children 

Human mobility in the Amazon ‘pushes malaria to cities’ 

The Medicines Patent Pool sublicenses sutezolid, an investigational drug for TB treatment, paving the way for clinical development 

Heart disease and stroke killing people in greater numbers than ever, WHO data show  

New alliance seeks to fight ‘plague’ of fake medicines 

DNDi 2020 Year in Review 

Human Rights Reader 557 

Almost 2 billion people depend on health care facilities without basic water services – WHO, UNICEF 

PRESS RELEASE: URGENT CALL FROM INTERNATIONAL CSO TO ECUADOR ON THE CHEVRON CASE 

Busting myths around the Energy Charter Treaty  

Energy Efficiency for Developing Countries: Pivoting from Fewer Inputs to More Outputs  

Dirty development dumped  

Green Deal: Sustainable batteries for a circular and climate neutral economy  

Global Health And Air Pollution Advocates Hail Landmark UK Court Ruling Recognizing Air Pollution As Factor In Child’s Death   

 

 

 

 

 

 

Fair Research Contracting – Key to Promoting Solidarity for Science and Development in a post-COVID-19 World

The institutional competence to negotiate and conclude equitable and fair research agreements and contracts usually differs significantly between partners in high income (HIC) compared to those in low-to middle-income (LMIC) countries. Legal expertise for competent research contract negotiation is very limited in LMICs, especially in the public sector. As negotiating contracts and agreements is essential to the ‘business of science’, to becoming globally competitive, and to fair public-private sector engagements, this lack of research contracting expertise in LMICs adds substantially to their continued economic and infrastructural disadvantage

 

By Carel IJsselmuiden, Kirsty Kaiser

COHRED, Switzerland

Abigail Wilkinson, Farirai Mutenherwa

School of Applied Human Sciences, University of KwaZulu-Natal, South Africa

 

 Fair Research Contracting

Key to Promoting Solidarity for Science and Development in a post-COVID-19 World

 

 

Fair research collaborations are borne from good contracts

Almost all research of any importance is done collaboratively between researchers in more than one organisation, often in more than one country. Typically, research collaborations in global health involve institutions from high income (HIC) and low-to middle-income countries (LMICs). Trust between the collaborating parties is essential for facilitating collaborations and reducing conflicts, for increasing equitability in research collaborations by encouraging fair sharing of outcomes, benefits and costs, and for building up the research institutions and systems in LMICs. This kind of trust can be firmly established through fair agreements and contracts between institutions.

Institutional competence in research contracting is as essential for institutional growth and sustainability as excellent science is for innovation and development. Having or having access to such competence should be a prerequisite for any research institution aiming to solve priority health, equity and development challenges. Many, if not all, renowned research institutions in high-income countries have their own centres of excellence in research contracting[1] and their governments provide support for those who lack such competence. [2]  In contrast, institutions in many LMICs are poorly equipped and lack access to expertise in this area. As negotiating contracts and agreements is essential to the ‘business of science’, to becoming globally competitive, and to fair public-private sector engagements, this lack of research contracting expertise in LMICs adds substantially to their continued economic and infrastructural disadvantage.

The massive health, financial, institutional and political implications of bringing a COVID-19 vaccine to market is the latest example of the crucial importance of having good contracts in place for vaccine research collaborations[3] [4].

Contracting capacity in LMICs

The institutional competence to negotiate and conclude equitable and fair research agreements and contracts usually differs significantly between partners in HICs compared to those in LMICs. Legal expertise for competent research contract negotiation is very limited in LMICs[5], especially in the public sector. As a result, in spite of international commitments to engage researchers in LMICs in COVID-19 research, it is entirely predictable that the increase in social and economic capital that will result from COVID-19 vaccine research will largely accrue to HICs. In fact, LMICs have been seriously under-represented in COVID-19 vaccine research [6] [7]. A recent update from the World Economic Forum suggests that LMICs are still not being included in research opportunities [8].  This is likely due to not having research systems that can handle this kind of research. And so, a vicious circle is born in spite of best intentions.

 

 

Conversely, if ample contracting expertise had been available to LMIC institutions participating in COVID-19 clinical research, for example, then much more institutional and research system strengthening could have resulted from these collaborations, LMICs would have been better prepared to participate in global research in a next pandemic and could have faster provided the solutions appropriate to LMICs where the need for intervention is most needed.[9] 

Turning the tables – enabling LMIC institutions to negotiate and conclude more equitable collaboration agreements

Fair research contracts can address systemic challenges in research capacity development in LMICs, supporting them on the road to becoming knowledge economies.[10]  A more reasonable share in outcomes and benefits can be re-invested in research system development. Fair Research Contracting[11] can help institutions and countries to better understand where they need to improve to become ‘research contracting competent’. If that happens, LMICs research systems can turn the tables – instead of relying on the goodwill of HICs, LMICs can negotiate and conclude collaboration agreement in ways that best suit their development priorities.

 

References

[1] https://www.ucl.ac.uk/research-services/research-contracts/what-research-contract-and-why-do-i-need-one

[2] The Lambert Toolkit. https://www.gov.uk/guidance/university-and-business-collaboration-agreements-lambert-toolkit

[3] Global coalition to accelerate COVID-19 clinical research in resource-limited settings. COVID-19 Clinical Research Coalition. (2020). https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30798-4/fulltext

[4] Borderless collaboration is needed for COVID-19—A disease that knows no borders. Mohamed et al. (2020). https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/borderless-collaboration-is-needed-for-covid19a-disease-that-knows-no-borders/CDC82720199AC7BE4654F123DB79508E

[5] Improving international research contracting. Sack et al. (2009). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704040/

[6] Consolidation in a crisis: Patterns of international collaboration in early COVID-19 research. Fry et al. (2020). https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0236307

[7] Scientific globalism during a global crisis: research collaboration and open access publications on COVID-19. Lee & Haupt. (2020). https://link.springer.com/article/10.1007/s10734-020-00589-0

[8] COVID-19: Collaboration is the engine of global science – especially for developing countries. Kituyi. (2020). World Economic Forum. https://www.weforum.org/agenda/2020/05/global-science-collaboration-open-source-covid-19/

[9] The need for COVID-19 research in low- and middle-income countries. Gupta et al. (2020). https://link.springer.com/article/10.1186/s41256-020-00159-y

[10] Fair Research Contracting.  A Self-Assessment Tool for Institutions. https://frcweb.cohred.org/wp-content/uploads/COHRED_SCNAT-FRC-Self-Assessment-Guide_V1.pdf

[11] Fair Research Contracting. http://frcweb.cohred.org (accessed 11 Dec 2020)

Covid-19 VIRAT and VRAF Country Assessment Tool

The issue of deployment of Covid-19 vaccines will be a big issue once it hits the market. Find a talk here on the Vaccine Introduction Readiness Assessment Tool (VIRAT), comprehensively referred to as the VIRAT/VRAF (Vaccine Readiness Assessment Framework) 2.0, whereby a workstream was constituted with the joint collaboration from partner agencies - like WHO, UNICEF, GAVI, World Bank, Bill and Melinda Gates Foundation Country Offices - and it was named the COVAX Country Readiness and Delivery Workstream

By Dr Tanushree Mondal

Associate Professor and Assistant Director of Medical Education, Government of West Bengal 

Covid-19 VIRAT and VRAF Country Assessment Tool

The Need of the Hour

 

This year 2020 has revealed a whole lot of secrets, and among those, one of the most salient was the Covid-19 pandemic. This not only took the lives of many innocent people, but at the same time, put the society at stake. With no vaccines around to offer protection, the pandemic seemed to surge its claws. Much had been said and researched about this deadly virus and its vaccine, yet no conclusive results are out yet. However, the countries are getting ready to combat the situation when the vaccine enters the Industry. The issue of deployment of such vaccines will be a big issue once it hits the market. This section talks of the Vaccine Introduction Readiness Assessment Tool, comprehensively referred to as the VIRAT/VRAF (Vaccine Readiness Assessment Framework) 2.0 [1]. This tool has been implemented in many countries post Covid like Sudan, Niger and many other countries.

A Workstream was constituted with the joint collaboration from partner agencies like WHO, UNICEF, GAVI, World Bank, Bill and Melinda Gates Foundation Country Offices and it was named the COVAX Country Readiness and Delivery Workstream [2].

Now what is so special about this tool?

This is a tool that is intended to help all the countries and their Ministries to:

  1. Assess the readiness to introduce COVID-19 vaccines which is the talk of the town
  2. Build a road map for vaccine introduction
  3. Avoid Data Duplications and minimize burden on the country’s resources
  4. Identify and analyze the gaps and prioritize actions in order to ensure enhanced readiness
  5. Identify opportunities for financial support through various partner organizations.

Now this tool measures ten key areas such as: Planning Coordination, Budgeting, Regulation, Prioritization and Covid-19 Surveillance, Service Delivery, Training & Supervision, Monitoring Evaluation, Vaccine and Cold Chain Logistics Infrastructure, Safety Surveillance, and last but not the least, Demand Generation and Communication. The tool does not end here, as it is supplemented by fifty more qualitative as well as quantitative indicators. All these information are entered into an Excel file.

The Excel Sheet has five different components, namely:

  1. General indications for use- It describes the timing and intervals to implement critical pre-planning activities. It also enables with activity and areas dashboards to give a graphic illustration of the progress achieved.
  2. National readiness  (Figure 1)
  3. Readiness dashboard activity (Figure 2)
  4. Readiness dashboard areas and
  5. Reference Page- It contains list of planning and technical documents like guidelines, guiding principles etc.

                                                                                                                                                      Figure 1

                                                                        Figure 2

The Supply Chain activities encompass a wide range of areas like strengthening national logistics working group, mapping key roles and responsibilities for vaccine deployment, mapping potential port(s) of entry, point(s) of storage and fallback facilities, assessing dry storage and cold chain capacity at all levels, establishing contractual agreements for vaccine introduction, provision of standard operating procedures for collection and disposal of medical wastes, updating vaccine stock management tools and establishing security arrangements to ensure integrity of the new vaccine.

With such a great initiative undertaken by the Workstream, we can hope for a better future ahead and thereby combat with our challenges that came alongside with the pandemic. 

————————

Essential Reading

[1]- COVID-19 vaccine introduction readiness assessment tool https://www.who.int/publications/i/item/WHO-2019-nCoV-Vaccine-introduction-RA-Tool-2020.1 

[2]- The country readiness and delivery workstream https://www.who.int/initiatives/act-accelerator/covax/covid-19-vaccine-country-readiness-and-delivery/act-accelerator-country-readiness-and-delivery-for-covid-19-vaccines